Alnylam Seeks To Advance RNAi Further With Inex Delivery Technology

 
• By Jonathan M. Block

There is an "open invitation" to companies and academia to partner with Inex on RNAi therapies, Inex CEO tells "The Pink Sheet" DAILY.

More from Archive

More from Pink Sheet